Showing results for Diabetes
-
VA funds IU School of Medicine research projects relevant to veterans’ health
IU School of Medicine researchers have cumulatively been awarded grant funding through the U.S. Department of Veterans Affairs to support research on diabetes, skin inflammation, ...
Aug 22, 2024 -
Five IU School of Medicine faculty honored among nation's top physician-scientists
Five Indiana University School of Medicine faculty have been recognized among the nation's top physician-scientists as 2024 members of the Association of American Physicians (AAP) ...
Mar 26, 2024 -
IU School of Medicine's 2023 NIH funding ranked No. 13 among public universities
Indiana University School of Medicine researchers received over $243 million in total funding from the National Institutes of Health during federal fiscal year 2023 — ...
Feb 20, 2024 -
Researchers reveal uncharted liver-focused pathway in gene therapy immune responses
Indiana University School of Medicine researchers have uncovered vital insights regarding a liver trigger that blocks an undesired immune response from gene therapy, surprisingly resulting ...
Dec 07, 2023 -
Repurposed drug offers new potential for managing type 1 diabetes
A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management ...
Nov 01, 2023 -
Defective closure of diabetic foot ulcers is associated with higher risk of wound recurrence
Results from a new study of diabetic foot ulcers and the risk of wound recurrence can help health care workers measure the likelihood that the ...
Jun 26, 2023 -
IU diabetes researchers discover new use for high blood pressure medication called verapamil
A clinical study conducted by Indiana University School of Medicine researchers revealed that oral verapamil, a readily available and commonly used drug to treat high ...
Mar 01, 2023 -
IU research contributes to first FDA-approved drug to delay onset of type 1 diabetes
Researchers at Indiana University School of Medicine are celebrating Federal Drug Administration approval of teplizumab, a new immunotherapy drug that delays the onset of type ...
Nov 21, 2022 -
IU School of Medicine-led study shows human induced pluripotent stem cells improve visual acuity, vascular health
Researchers are investigating novel regenerative medicine approaches to better manage vascular health complications from type 2 diabetes that could someday support blood vessel repair in ...
Mar 10, 2022 -
Synthetic hinge could hold key to revolutionary “smart” insulin therapy
For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them—an ...
Jul 29, 2021